Table 2 Costs of drugs and rescue treatment
Study drug costs | Cost (JPY) (Range for one-way sensitivity analysis) | Distribution type for PSA | Reference |
|---|---|---|---|
Olanzapine 5.0 mg (oral) | 150.4 (28.9 ~ 150.4) | Did not vary | NHI price list |
Aprepitant 125 mg (oral) | 1659.4 | Did not vary | NHI price list |
Aprepitant 80 mg (oral) | 1125.0 | Did not vary | NHI price list |
Palonosetron 0.75 mg (intravenous) | 5349.0 | Did not vary | NHI price list |
Dexamethasone 4.0 mg (oral) | 29.9 | Did not vary | NHI price list |
Non-olanzapine regimen (APR + PALO + DEX) | 9527.5 | Did not vary | NHI price list |
Olanzapine regimen (OLA + APR + PALO + DEX) | 10,129.1 (9643.1 ~ 10,129.1) | Did not vary | NHI price list |
Rescue treatments (IC for acute phase) | 833.8 (167.1 ~ 1500.5) | Normal (Mean = 833.8, SE = 340.1) | [24] |
Rescue treatments (CC for acute phase, IC for delayed phase) | 286.5 (97.3 ~ 475.7) | Normal (Mean = 286.5, SE = 96.5) | [24] |